{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:48:50Z","timestamp":1765547330369,"version":"3.37.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijrobp.2024.10.017","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:28:23Z","timestamp":1730208503000},"page":"1026-1038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Irradiated Bone Marrow Volume is Associated With Hematologic Toxicity in Patients With Multiple Myeloma"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-7781","authenticated-orcid":false,"given":"Samuel C.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Steers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Stiehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina D.","family":"Silos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giana","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Oorloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taman","family":"Upadhaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Vescio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Oveisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrooz","family":"Hakimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn M.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5510-1691","authenticated-orcid":false,"given":"Leslie K.","family":"Ballas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.10.017_bib0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0360-3016(93)90308-I","article-title":"Radiation therapy for the palliation of multiple myeloma","volume":"25","author":"Leigh","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0002","article-title":"Effective pain control with very low dose palliative radiation therapy for patients with multiple myeloma with uncomplicated osseous lesions","volume":"6","author":"Price","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0003","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clml.2014.07.010","article-title":"Feasibility and efficacy of local radiotherapy with concurrent novel agents in patients with multiple myeloma","volume":"14","author":"Shin","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.adro.2018.09.009","article-title":"The safety profile of concurrent therapy for multiple myeloma in the modern era","volume":"4","author":"Resende Salgado","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0005","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3390\/cancers14092273","article-title":"RR Myelo POINT: A retrospective single-center study assessing the role of radiotherapy in the management of multiple myeloma and possible interactions with concurrent systemic treatment","volume":"14","author":"Guerini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0006","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3390\/cancers15112909","article-title":"Radiotherapy in combination with systemic therapy for multiple myeloma-A critical toxicity evaluation in the modern treatment era","volume":"15","author":"Oertel","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0007","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood.2020005288","article-title":"Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: The GRIFFIN trial","volume":"136","author":"Voorhees","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000-2014","volume":"31","author":"Fonseca","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0009","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0010","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1182\/blood.V73.6.1677.1677","article-title":"Hematopoietic bone marrow recovery after radiation therapy: MRI evaluation","volume":"73","author":"Casamassima","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0360-3016(77)90003-7","article-title":"Long-term side effects in irradiated patients with Hodgkin's disease","volume":"2","author":"Slanina","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0012","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1097-0142(197309)32:3<699::AID-CNCR2820320324>3.0.CO;2-V","article-title":"Bone marrow regeneration and extension after extended field irradiation in Hodgkin's disease","volume":"32","author":"Rubin","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0013","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0014","article-title":"Biological effective radiation dose for multiple myeloma palliation","volume":"8","author":"Meredith","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0015","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.ijrobp.2023.06.068","article-title":"Phase II multi-institutional study of a low-dose (4 Gy) palliative response-adapted radiotherapy regimen for symptomatic bone metastases from multiple myeloma: Planned interim analysis of first 40 patients","volume":"117","author":"Ballas","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0016","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","article-title":"Radiation therapy for solitary plasmacytoma and multiple myeloma: Guidelines from the International Lymphoma Radiation Oncology Group","volume":"101","author":"Tsang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0017","unstructured":"National Comprehensive Cancer Network. Hodgkin lymphoma version 3.2024. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1439. Accessed April 11, 2024."},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0018","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0019","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0020","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0021","first-page":"445","article-title":"Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment","volume":"25","author":"Bradford","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0022","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1073\/pnas.96.6.3120","article-title":"In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells","volume":"96","author":"Cheshier","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0023","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1467-9876.2005.00510.x","article-title":"Generalized additive models for location, scale and shape","volume":"54","author":"Rigby","year":"2005","journal-title":"J R Stat Soc C"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0024","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/sim.746","article-title":"Worm plot: A simple diagnostic device for modelling growth reference curves","volume":"20","author":"van Buuren","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0025","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1080\/03610920701215639","article-title":"A stepwise AIC method for variable selection in linear regression","volume":"36","author":"Yamashita","year":"2007","journal-title":"Commun Stat Theor Methods"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"year":"2015","series-title":"R: A Language and Environment for Statistical Computing","key":"10.1016\/j.ijrobp.2024.10.017_bib0027"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: A phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0029","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ijrobp.2011.12.072","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal","volume":"84","author":"Bazan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2014.09.002","article-title":"Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy","volume":"113","author":"Yang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0031","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2015.12.374","article-title":"Long-term bone marrow suppression during postoperative chemotherapy in rectal cancer patients after preoperative chemoradiation therapy","volume":"94","author":"Newman","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0032","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00066-015-0841-3","article-title":"Early hematologic changes during prostate cancer radiotherapy predictive for late urinary and bowel toxicity","volume":"191","author":"Pinkawa","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0033","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S1470-2045(18)30528-X","article-title":"Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG\/RTOG 9413): Long-term results of a randomised, phase 3 trial","volume":"19","author":"Roach","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0034","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2016.01.022","article-title":"Hematologic toxicity in patients treated with postprostatectomy whole-pelvis irradiation with different intensity modulated radiation therapy techniques is not negligible and is prolonged: Preliminary results of a longitudinal, observational study","volume":"95","author":"Cozzarini","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1088\/0031-9155\/5\/3\/302","article-title":"The distribution of active bone marrow in the adult","volume":"5","author":"Ellis","year":"1961","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0037","first-page":"129","article-title":"Pain assessment: Global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0038","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijrobp.2016.11.027","article-title":"Bone Marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)","volume":"97","author":"Mell","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0039","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2021.08.019","article-title":"Positron emission tomography-guided bone marrow-sparing radiation therapy for locoregionally advanced cervix cancer: Final results from the INTERTECC phase II\/III trial","volume":"112","author":"Williamson","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0040","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3390\/cancers12113306","article-title":"Bone marrow-sparing IMRT in anal cancer patients undergoing concurrent chemo-radiation: Results of the first phase of a prospective phase II trial","volume":"12","author":"Arcadipane","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0041","first-page":"3315","article-title":"In vivo validation of 3\u2019deoxy-3\u2019-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: Correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors","volume":"8","author":"Vesselle","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0042","first-page":"1592","article-title":"18F-FLT PET in hematologic disorders: A novel technique to analyze the bone marrow compartment","volume":"47","author":"Agool","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109564","article-title":"F-18 FDG PET\/CT and F-18 FLT PET\/CT as predictors of outcome in patients with multiple myeloma. A pilot study","volume":"136","author":"Gallicchio","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0167-8140(84)80062-6","article-title":"The paradoxes in patterns and mechanism of bone marrow regeneration after irradiation. 1. Different volumes and doses","volume":"2","author":"Scarantino","year":"1984","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0045","first-page":"326","article-title":"Effects of radiations on bone marrow","volume":"27","author":"Tubiana","year":"1979","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0046","first-page":"421","article-title":"FDG PET imaging in multiple myeloma: Implications for response assessments in clinical trials","volume":"8","author":"Sundaram","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0047","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.adro.2020.03.021","article-title":"Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma","volume":"5","author":"So","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0048","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0049","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.3390\/cancers13246193","article-title":"Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: A secondary analysis of RTOG0617","volume":"13","author":"Jin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.017_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110030","article-title":"The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC","volume":"190","author":"Friedes","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624035090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:46:48Z","timestamp":1740134808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624035090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0360301624035090"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.017","relation":{},"ISSN":["0360-3016"],"issn-type":[{"type":"print","value":"0360-3016"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irradiated Bone Marrow Volume is Associated With Hematologic Toxicity in Patients With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}